FDA Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of FDA Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Allergies
Studies Showed Fluticasone Furoate Nasal Spray Was Well-Tolerated and Effective in Treating Allergic Rhinitis in Pediatric Patients
March 15th, 2007
Four out of every 10 children suffer from severe nasal allergy symptoms that may affect their overall well-being. Now, clinical research suggests that fluticasone furoate nasal spray (FFNS), a once-a-day allergy medicine under Food and Drug Administration review, effectively treats sneezing, runny nose, nasal itching, and nasal congestion in children 2 to 11 years of age with seasonal and year-round nasal allergies. Moreover, the investigational drug had no effect on children's short-term growth. Data from these studies, including two Phase III trials (poster #1193, 1189) involving more than 1,100 children, were presented today at the annual meeting of the American...
Source: FDA Law Weekly (2007-03-15)
|
